Editorial [ Risk Benefit: Who is Responsible? ]

Publisher： Bentham Science Publishers

E-ISSN： 2212-3903|2|1|1-1

ISSN： 1574-8855

Source： Current Drug Therapy, Vol.2, Iss.1, 2007-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk-Benefit Assessment of Methotrexate in the Treatment of Severe Psoriasis

By Kuijpers A.L.   van der Kerkhof P.C.M.  

American Journal of Clinical Dermatology, Vol. 1, Iss. 1, 2000-01 ,pp. : 27-39

Adis International

Access to resources Recommend Favorite

Qualitative and Quantitative Assessment of the Benefit-Risk Ratio of Medium Potency Topical Corticosteroids In Vitro and In Vivo : Characterisation of Drugs with an Increased Benefit-Risk Ratio

By Schackert C.  

BioDrugs, Vol. 13, Iss. 4, 2000-04 ,pp. : 267-277

Adis International

Access to resources Recommend Favorite

Séparation des énantiomères : pour quelle amélioration du rapport bénéfice/risque ?: Chiral Switch: Towards a Better Benefit-Risk Ratio?

By Blin Olivier  

Therapie, Vol. 59, Iss. 6, 2004-01 ,pp. : 625-628

Adis International

Access to resources Recommend Favorite

Effects of 5-Form, Yang Style Tai Chi on older females who have or are at risk for developing osteoporosis

By Murphy Lori   Singh Betsy  

Physiotherapy Theory and Practice, Vol. 24, Iss. 5, 2008-09 ,pp. : 311-320

Informa Healthcare

Access to resources Recommend Favorite

Factors Influencing HIV Risk Among Hispanic Men Who Have Sex With Men

By De Santis Joseph P.  

Hispanic Health Care International, Vol. 8, Iss. 3, 2010-09 ,pp. : 122-124

Springer Publishing Company

Access to resources Recommend Favorite